DOD Biotech PCL Statistics

Total Valuation

DOD Biotech PCL has a market cap or net worth of THB 900.83 million. The enterprise value is 719.14 million.

Market Cap	900.83M
Enterprise Value	719.14M

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

DOD Biotech PCL has 450.41 million shares outstanding. The number of shares has increased by 25.52% in one year.

Current Share Class	450.41M
Shares Outstanding	450.41M
Shares Change (YoY)	+25.52%
Shares Change (QoQ)	+0.66%
Owned by Insiders (%)	12.46%
Owned by Institutions (%)	19.52%
Float	350.04M

Valuation Ratios

The trailing PE ratio is 28.06.

PE Ratio	28.06
Forward PE	n/a
PS Ratio	1.36
PB Ratio	0.98
P/TBV Ratio	1.02
P/FCF Ratio	64.96
P/OCF Ratio	20.40
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.91, with an EV/FCF ratio of 51.86.

EV / Earnings	-5.43
EV / Sales	1.08
EV / EBITDA	8.91
EV / EBIT	24.41
EV / FCF	51.86

Financial Position

The company has a current ratio of 3.05, with a Debt / Equity ratio of 0.05.

Current Ratio	3.05
Quick Ratio	2.02
Debt / Equity	0.05
Debt / EBITDA	0.56
Debt / FCF	3.25
Interest Coverage	9.68

Financial Efficiency

Return on equity (ROE) is 2.98% and return on invested capital (ROIC) is 1.68%.

Return on Equity (ROE)	2.98%
Return on Assets (ROA)	1.47%
Return on Invested Capital (ROIC)	1.68%
Return on Capital Employed (ROCE)	3.10%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.53
Inventory Turnover	3.63

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.08% in the last 52 weeks. The beta is 0.77, so DOD Biotech PCL's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	-23.08%
50-Day Moving Average	1.34
200-Day Moving Average	1.85
Relative Strength Index (RSI)	71.75
Average Volume (20 Days)	2,433,275

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DOD Biotech PCL had revenue of THB 664.77 million and -132.39 million in losses. Loss per share was -0.29.

Revenue	664.77M
Gross Profit	222.75M
Operating Income	29.46M
Pretax Income	41.04M
Net Income	-132.39M
EBITDA	78.03M
EBIT	29.46M
Loss Per Share	-0.29

Full Income Statement

Balance Sheet

The company has 223.07 million in cash and 45.07 million in debt, giving a net cash position of 178.01 million or 0.40 per share.

Cash & Cash Equivalents	223.07M
Total Debt	45.07M
Net Cash	178.01M
Net Cash Per Share	0.40
Equity (Book Value)	922.13M
Book Value Per Share	2.06
Working Capital	296.90M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 44.15 million and capital expenditures -30.29 million, giving a free cash flow of 13.87 million.

Operating Cash Flow	44.15M
Capital Expenditures	-30.29M
Free Cash Flow	13.87M
FCF Per Share	0.03

Full Cash Flow Statement

Margins

Gross margin is 33.51%, with operating and profit margins of 4.43% and -19.91%.

Gross Margin	33.51%
Operating Margin	4.43%
Pretax Margin	6.17%
Profit Margin	-19.91%
EBITDA Margin	11.74%
EBIT Margin	4.43%
FCF Margin	2.09%

Dividends & Yields

DOD Biotech PCL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.52%
Shareholder Yield	n/a
Earnings Yield	-14.70%
FCF Yield	1.54%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DOD Biotech PCL has an Altman Z-Score of 3.89.

Altman Z-Score	3.89
Piotroski F-Score	n/a